'Vaccine for the world' approved in UK: Key things to know about Oxford COVID-19 vaccine
'Easy to produce' and 'easy to handle' Oxford-AstraZeneca COVID-19 vaccine would become 'vaccine for the world', the developers believed. Know the key details
Britain on Wednesday became the first country to approve a coronavirus vaccine developed by Oxford University and AstraZeneca. Dubbed as AZD1222, the vaccine showed an average efficacy of 70.4%, with no hospitalisations or severe disease, the University of Oxford mentioned earlier. 'Easy to produce' and 'easy to handle' Oxford-AstraZeneca COVID-19 vaccine would become “vaccine for the world," the developers believed.